Live feed06:31:23·580dSECFilingvia QuantisnowMatinas Biopharma Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.MTNB· Matinas Biopharma Holdings Inc.Health CareOriginal source
